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ABSTRACT
Objective: To current review the literature regarding safety and effectiveness of electronic cigarettes and to find out any con-
tribution from Malaysia, regarding electronic cigarettes research field.
Design: To commendably face this new challenge, health care providers need to become more familiar with the existing liter-
ature. A narrative review studies conducted from 2004 to August 2014 through multiple electronic databases that available at 
the author's institution library conducted by using the terms, safety, effectiveness, efficacy, chemical analysis of e-cigs, electron-
ic cigarettes or electronic nicotine delivery system (ENDS). The databases searched only for full text papers published in English 
from 2004 to august 2014. 
Methods: 48 original articles identified with help of multiple electronic databanks, that linked to aim title were selected. 
Nation wise contribution included, USA(16), UK(07), Italy(6), Greece(5), New Zealand(5), Switzerland(4), Canada, Australia, 
Poland, south Korean, Czech republic each 1. We did not found any article from Malaysia, this indicate us there is a necessity of 
electronic cigarettes studies on Malaysian population.
Conclusion: Due to limited studies with inadequate participants and short time exposure in some developed countries, e-cig 
cannot accomplish safe and effective in complete terms. In order to conclude firmly, still more research is needed globally in dif-
ferent population to look at its long-term safety and effectiveness particularly on cardiovascular diseases and on smoker’s health 
from different parts of the world.
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Electronic cigarettes (e-cigs) are gaining popularity and its use rises 
sharply every year. According to recent report prepared by world health 
organisation (WHO) stated that, till early 2014 there are 466 brands of 
e-cigs available in 7764 unique flavours(Zhu et al., 2014) and till the 
end of 2013 its sales reached to US$ 3 billion globally and it has been 
projected, the sales margins can rise up to US$10 by 2017(Herzog B et 
al., 2014).Worldwide there is no data for e-cig users (commonly called 
vapers). However data from some country suggested that, like North 
America, the European Union and republic of Korea, the e-cig users 
doubled among both adults and adolescents from 2008 to 2012(Grana et 
al., 2014). The spectacular success of e-cigs is a game-changing event 
in the field of tobacco control and even the tobacco industry has intro-
duced their own brands.
Electronic cigarettes (e-cigs) are relatively new and the use is 
becoming a popular type of electronic nicotine delivery system (ENDS). 
It is a battery-powered device that looks like a cigarette but does not 
involve smoke and which enables users to inhale vaporized nicotine 
(WHO, 2009). The e-cigarette was developed with the goal of mimick-
ing the action of smoking, including nicotine delivery, without the toxic 
effects of tobacco smoke which is responsible for nearly all of tobacco 
smoking's damaging effect (Cahn and Siegel, 2011; Siegel et al., 2011; 
Borland 2011; Foulds et al., 2011; and Wagener et al., 2012). Further 
e-cigs generating vapours which visually look like smoke, that replace 
most of the bodily, civic and societal elements linked with smoking.
E-cigs transport to the lungs, a chemical mixture primarily consists 
of nicotine, propylene glycol, glycerine and few flavouring agents. They 
are often tactically look and feel like cigarettes. They have been promot-
ed as substitutes to cigarettes and for usage in places where smoking is 
not tolerable since they do not generate smoke. They are also sometimes 
made to look like daily normal items such as pens, screw driver for peo-
ple use so that, its appearance deprived of other people observing 
(WHO. 2009).
Concept of an E-cigarette was first patented in 1965 by Herbert A 
Gilbert (Gilbert, 1965). But then again the 21st century creation of e-cig-
arettes is recognized to Mr Hon Lik, a Chinese pharmacist (Kcancer, 
2010). The device was first introduced to the Chinese domestic market 
in May 2004 as a support for smoking cessation. Then export began in 
2005-2006, before an international patent in 2007.
A typical e-cigarette (Figure1) is made up of electronic vaporization 
system (contains heating coil), rechargeable batteries, electronic circuit 
and tanks to fill the e-juice to vaporize. The amount of nicotine in the 
e-juice may differ, the manufacturer's stated that the e juice typically 
contain between 6 and 24 mg of nicotine (Goniewicz et al., 2012). 
Currently due to advancement of technology there are three categorizing 
of E-cigarettes available in the markets. Namely Ist generations (looks 
like traditional tobacco cigarettes), IInd generations (look like pens and 
screw drivers also called vape pens) or IIIrd Generations (also called 
advanced personal vaporizers (APVs or Modes). Each type gets gradu-
ally larger as you move up from Ist Generations to IIIrd Generations. Ist 
being the smallest and IIIrd or APVs being the largest.
From Ist generation to third Generations, there is an improvement in 
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features like improvement in battery life, use of different atomisers with 
various e-liquid filling capacities, advanced features such as variable 
voltage (VV) and / or variable wattage (VW), all these factors are 
important for better vapour productions and to increase the number of 
puffs. 
There is rising curiosity as well as worry regarding e-cigs among 
cigarette smokers, entrepreneurs, health care professionals, policy man-
agers and even tobacco industries. The World Health Organization has 
urged marketers of e-cigarettes to halt their unproved claims about the 
therapeutic benefits of using e-cigarettes and has indicated that there is 
no reliable scientific evidence to confirm the product's safety and effica-
cy (WHO, 2008). Certain believers of tobacco harm reduction have 
pointed to these products as feasible alternatives for cigarettes because 
they produce fewer toxins in the vapour delivered to the use (Cahn and 
Siegel, 2011; Siegel et al., 2011; Borland , 2011; Foulds et al.,2011; 
Wagener et al., 2012).
Cigarette smoking
Smoking is a chief source of adverse health effects in most coun-
tries globally. Smoking harms nearly every single organ of the body. 
Smoking origins many diseases and shrinks the health of smokers in 
over-all (WHO, 2003). Cigarette smoking is the single biggest avoidable 
cause of death and disability in developed countries. Smoking is now 
growing swiftly all over the world and is one of the biggest intimida-
tions to current and future world health (WHO, 2003). For many smok-
ers, leaving smoking is the chief imperative thing they can do to 
improve their health. Reassuring smoking cessation is one of the abso-
lute cost effective things that physicians and other health professionals 
can do to improve health and prolong their patients' lives. The adverse 
health effects of smoking are wide, and have been comprehensively rec-
ognized. There is a substantial dose-response link with heavy smoking, 
duration of smoking, and premature use connected with higher risks of 
smoking related illness and mortality (Wilson et al., 2000).
Global Smoking statistics
Tobacco smoking is a global problem, affecting an approximately 
1.3 billion people, projected to increase 1.6 billion by 2025 that create 
significant health problem and economic burden (Mathers & Loncar, 
2006). According to the World Health Organization (WHO) tobacco use 
is presently accountable for the death of one in ten adults’ worldwide. 
Presently 6 million deaths and this number of deaths due to smoking-re-
lated diseases are expected to reach 8.3 million by 2030 (WHO, 2008; 
US Department of Health and Human Services, 1990). 
METHODS
A literature survey was done from March to August 2014 to identify 
published articles related to safety and effectiveness of electronic ciga-
rettes. In this narrative review, we included studies that are potentially 
related to safety and effectiveness of Electronic cigarettes including 
chemical analysis, because it addresses the safety of device. Each article 
was revised by all authors and a consent meeting was summoned to 
ensure worth assurance of the manuscript.
The searched scheme involved nine most widely used electronic 
databases in health sciences, that included Medline, PubMed, Scopus, 
ISI Web of knowledge, science direct, Springer link, JSTOR, Proquest 
and Ebsco Host. The searched structure involved using Boolean opera-
tors for combination of the following terms: safety, effectiveness or effi-
cacy, chemical analysis, electronic cigarettes, e-cigarettes, nicotine 
delivery system. These searches were accompanied by hand search of 
the reference lists in the reports identified. To ensure reports met the 
desired criteria, the lists of titles and abstracts from searches were scru-
tinized and where doubt remained, the whole paper was examined. The 
searched was limited to full papers articles published in English from 
2004 to August 2014.
RESULTS
185 titles and abstracts were identified by all authors from above 
mention nine databanks and wherever possible by valuation of the refer-
ence lists. Among these Articles that includes, Erratum, book chapters, 
reviews, letter to editors, short communications, editorials notes, opin-
ions, non-original data, not published in English language and duplicat-
ed citations were examined and excluded. Of these, 72 original articles 
that related to our topic were selected.. The full text of 72 articles was 
retrieved and disseminated among all authors for further valuation. 
Among 72 documents all authors agreed that, 48 were suitable for inclu-
sion in the review. Country wise contribution include, USA(16), 
UK(07), Italy(6), Greece(5), New Zealand(5), Switzerland(4), Canada, 
Australia, Poland, south Korean and Czech republic each 1. We did not 
found any article from Malaysia, this indicate us there is a need of elec-
tronic cigarettes studies on Malaysian population. The remaining manu-
scripts were excluded because their primary focus was not safety, effec-
tiveness and chemical analysis of electronic cigarettes. So in the final 
review mainly 48 articles were selected. Although some other articles 
are also cited for background and context. The quorum flow chart for 
this review is shown in (Figure 2).
Studies on Effectiveness of E-Cigarette
Evidences strongly suggest that e-cigarettes may be effective in 
helping smokers to quit and preventing relapse, to our knowledge there 
have been few published studies to explain why this might be the case. 
Many health authorities refuse to say that, this product is beneficial for 
smoking cessation due to limited studies and the risks and benefits are 
still being calculating. The degree of effectiveness depends on what 
effect is being measured. 
As per the Goniewicz et al., (2013) quitters perceive mainly four 
benefits these are, desire to smoke (craving), help to cut down ciga-
rettes, help to quit entirely and eradicate the smell of stale smoke.
Figure 1. structure of standard entry model Electronic cigarette
 Source: http://www.e-cigarettedirect.com/pages/How-E-Cigs-Work.html
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Some online surveys on e-cigarette users suggested that, e-cigarette 
helped them to quit or reduce smoking and vapers believe that it is less 
harmful than smoking (Etter, 2010; Etter & Bullen, 2011; Siegel et al., 
2011; Foulds et al., 2011).
The trial by Bullen et al., 2010 on 40 naїve smokers measured the 
short-term effects of e-cigarettes on desire to smoke, withdrawal symp-
toms, acceptability, pharmacokinetic properties and adverse effects in a 
cross-over trial design. The results demonstrated that electronic ciga-
rettes deliver nicotine effectively, more rapidly than a nicotine inhaler, 
and the electronic cigarette use significantly reduced craving but less 
than with a regular cigarette (Bullen et al., 2010).
The Siegel et al., (2011) on 216 respondents, more than 70% male 
between 18 to 65 ages smoking for last 5-30 years, reported after 6 
months of vaping, 31% of participants were no longer using tobacco 
cigarettes.
The clinical trial done by Caponnetto, P et al.,( 2013a) on 300 
smokers in a randomized clinical trial (RCT) with no intention to quit 
,performed the efficiency and safety of an electronic cigarette (ELCAT), 
have found out smoking reduction was documented in 22.3% and 10.3% 
at week-12 and week-52 respectively. Complete abstinence from tobac-
co smoking was documented in 10.7% and 8.7% at week-12 and week-
52 respectively. Declines in cig/day use and expired carbon monoxide 
(eCO) levels were observed and a substantial decrease was found in the 
adverse events as well. In another study by same author on 14 chronic 
schizophrenic smokers reported similar reductions in cigarette con-
sumption and abstinence after a yearlong trail by using e-cigs 
(Caponnetto et al., 2013b).
The clinical trial done by Polosa, R et al., (2011) in a 6 month pilot 
study on 40 regular smokers with no desire to quit, reported a six-month 
prevalence smoking cessation rate of 22.5%. An additional 32.5% of 
smokers reduced their cigarette consumption by at least 50% by using 
e-cigarettes. The Polosa et al continued the trial in a naturalistic settings 
have been found out a 50 % reduction in the number of cig/day after 24 
months was shown in 27.5 % participants with a median of 24 cig/day 
use at baseline decreasing significantly to 4 cig/day (p = 0.003). 
Smoking abstinence was reported in 12.5 % participants while com-
bined 50% reduction and smoking abstinence was observed in 40% par-
ticipants in two years (Polosa, R et al., 2013).
The trial by Dawkins et al., 2012 in 86 smokers, examined whether 
the e-cigarette can reduce desire to smoke and abstinence-related with-
drawal symptoms among three groups during 0, 5, 20 minutes period 
after vaping ad libitum for 5minuttes. It was found that the electronic 
cigarette can reduce desire to smoke and nicotine withdrawal symptoms 
20 min after its use. In another study by same author, on 1347 partici-
pants from 33 countries (> 70% European) online survey reported that, 
e-cig are mostly used for smoking cessation, but need a longer duration 
than nicotine replacement therapies (Dawkins et al., 2013).
The survey conducted by Goniewicz et al., (2013) on 179 respon-
dents reported that 72% of users believed that e-cigs were beneficial in 
reducing cravings and withdrawal symptoms while 92% declared that 
the devices had reduced the number of conventional cigarettes they 
smoked. Indeed, in the same survey, 96% of former smokers claimed 
that e-cigarettes had helped them quit, and 79% reported a fear that if 
they stopped using them they would start smoking again.
In study done by Barbeau et al.,(2013) on 11 participants ages 
between 18-64 in a focus group discussion posing open ended ques-
tions, revealed that, vaping was more successful in maintaining cigarette 
abstinence than FDA approved NRT therapies due to retention of 
behavioural and social element of smoking dependence .
Farsalinos et al., (2013) recruited 111 participants more than 84% 
male smoked smoked before at least 20 30 cigs/day, who had complete-
ly substituted conventional cigarette with e-cig for last one month 
shown, e-cig with high nicotine content were more successful in the 
smoking abstinence process.
Kralikova et al., (2013) taken interview of 2012 participants on the 
street of 17 cities of Czech republic, identified that about 20% of smok-
ers who tried e-cigs go on to become regular e-cig users (Kralikova et 
al., 2013).
Pokhrel et al.,( 2013 ) in a cross sectional study survey on Hawaiian 
islands on 1567 participants shown, smokers who tried e-cigs appear to 
be more serious about smoking cessation and treat e-cig as valid alterna-
tive to FDA approved nicotine replacement therapies.
A randomized controlled trial on large number of participant done 
by Bullen et al., (2013) to verify safety and effectiveness of e-cigs 
among 657 people shows that e-cigs, with or without nicotine, were 
modestly effective at helping smokers to quit, with similar abstinence 
rate achieved with nicotine patches. However, the study was underpow-
ered to conclude superiority of nicotine over nicotine patches (Bullen et 
al., 2013). 
A recently worldwide survey of more than 19,000 consumers by far-
salinos et al., (2014) on characteristics, perceived side effects and bene-
fits of electronic cigarette use reported, E-cigs were mostly used to 
avoid the harm associated with smoking and it is effective in highly-de-
pendent smokers and are used as long-term substitutes for smoking. The 
study also stated 57.9% participants faced at least one symptoms and the 
most common side effect were dry mouth and sore throat (38.9%) .
A new recent cross sectional population study on 5863 adults to quit 
smoking with smoking aids such as E-cig, nicotine replacement therapy 
(NRT) and deprived of smoking aid for smoking cessation, were select-
ed in a real world settings without professional support. Among smok-
ers, who more likely to report for quit smoking were E-cig users com-
pare to NRT and no aid cessation users respectively (Brown et al.,2014).
An outline of the studies involving effectiveness of e-cigs, summa-
rized in the Table 1
Studies on E-Cigarettes Safety
A draft review by the WHO's Tobacco Regulatory Group in 2009 
notes that the extent of nicotine uptake and the safety of e-cigarettes 
have yet to be fully established. Most of the safety concerns regarding 
electronic cigarettes relate to the absence of appropriate product regula-
tion and inconsistencies in quality control (WHO 2009).
The study done by Eissenberg (2010) on 16 smokers, naive to e-cig-
arettes were cycled through the four device groups revealed that, smok-
ing but not vaping , notably increase nicotine and heart rate (Eissenberg, 
T .2010).
The trails done by vansickel et al., (2010) in above correlated situa-
tion, reported similar results. The key findings were, nicotine, expired 
carbon monoxide and heart rate all increased after smoking, but not vap-
ing, but later in 2013 Vansickel and Eissenberg study on 8 experienced 
E-cig users reported that, both smoking and vaping induced similar con-
comitant increases in heart rate and blood levels of nicotine (vansickel 
et al., 2010 ;2013).
The results reported by Etter and Bullen (2011) on 31 respondents 
of e-cigarettes users from different countries after vaping ad libitum but 
abstained from cigarettes and NRTs for 48hrs. The study shown vaping 
and smoking induce similar increases in salivary cotinine levels than 
conventional cigarettes
Czogala et al., (2012) have done comparison study on hemodynam-
ic parameters (Systolic and diastolic pressure, pulse and heart rate) in 
smokers and vapers on 42 subjects. The study shown that vaping e-ciga-
Figure 2. Quorum flow chart of the review process
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Table 1. Summary of studies involved in effectiveness of Electronic Cigarettes.
Authors Study design  Patient sample size Clinical outcomes and key findings 
Bullen et al., (2010) RCT, four groups comparison effect E-cig  40 adult naїve dependent smokers Tobacco cigarette effectively remove craving and
Australia. with or without nicotine, tob cigarette &  Average age (mean ± SD): 47.6 ± 12.4  withdrawal symptoms'-E-cig with nicotine and
 Nicorette nicotine inhaler  nicotine inhaler have similar effect greater than
   e-cig without nicotine.
 Online French survey 81 participants,  between 19-65, 63% e-cigarette helped to  quit smoking
Etter (2010).
   former smokers 23% daily smokers  
  13% occasional smokers from 
  different country
 Internet survey  3587 respondents, between 31-52,  Respondent reported E-cigs helped them to quit or 
Etter and Bullen, (2011)  70% former smokers, 19% daily  decreased smoking and vaping less toxic than
  smokers 11% occasional smokers  smoking.
Foulds et al., (2011). Survey at e-cig enthusiast convention  104  respondents mean between   E-cig helped them to quit or decreased cigarette  
(interview)   34 ± 9, 78% former smokers, 19%  consumption and vaping less harmful than smoking
  daily smokers 
Siegel et al., (2011). Online survey  216 participants ages 18-65 ± years ,  After 6 months of E-cig 31% of participants were 
  smokers for 5-30 + years  no longer using tobacco cigarettes.
Dawkins et al., (2012). RCT; single-blind 86 e-cigarette naïve smokers (43  E-cig helped to decreased desire to smoke and 
  female, 43 male; age range:  abstinence related withdrawal symptoms over a 20
  18-52 [mean: 28.8 minutes period. 
Bullen  et al., (2013) Randomized controlled trail on  e-cig group(n = 289) age 44 ± 13  E-cig with or without nicotine were effective at 
 657respondents. years, nicotine patch group(n = 295)  helping smokers to quit smoking as nicotine 
  age 40 ± 13 years e-cig placebo  patches 
  group (n = 73), age 43 ± 12 years
Barbeau et al., (2013). Focus group discussions facing open   Nine men and two women, between  Participants reported E-cig is more helpful than   
 ended  questions 18-64 years FDA approved nicotine replacement therapies due  
   to retention of behavioral and social components of 
   smoking addiction
Caponnetto et al., (2013a). RCT: prospective 12-month randomized,  300 smokers no intention to quit, The use of e-cig with or without nicotine , decreased
 controlled trial. mean age 44 ± 13 years, 63% male  cigarette consumption and elicited tobacco
  and smoke at least 15-25  abstinence 
  cigarettes/day
Caponnetto et al., (2013b). Chronic schizophrenic patients observed   14 Chronic schizophrenic patients e-cig use decreased cigarette consumption without 
 for 12 months   mean age 45±13 years and consumed   causing any significant side effects in schizophrenic
  20-35 cigarette /day  patients
Dawkins et al., (2013).  Online survey  1347 participants, mean age 43 years  E-cig mainly used to quit smoking .study also
  Respondents from 33 countries. reported there is very little evidence that E-cig is 
   not the gateway for nonsmokers.
Farsalinos et al., (2013).  Smokers substituted  with e-cig for at  111 participants, average  37 ± 6 E-cig with higher nicotine useful in quit smoking
 least 1 month  years, smoked 20-30 cig/day from  compare to less or no nicotine.
  Greece.  
Goniewicz et al., (2013a). Internet survey   179 respondents from Poland  E-cig mainly used to quit smoking with less harm  
   effects.
Polosa et al., (2013). A 24 month observational study  40 regular smokers, 26 males, 14  After Long term e-cig use decreased in > 50% con-
  females; mean ± SD age of 42.9 ± 8.8  sumption of traditional cigarette along with 12.5% 
  years Regular smokers (mean ± SD):  of abstinence rate as verified eCO(exhaled carbon
  34.9 ± 14.7 pack/years.  monoxide).
Polosa et al., (2011). A prospective 6 month pilot study  40 regular smokers, 26 males, 14  After 6 month , E-cig decreased  50 to 80% consump-
  females; mean ± SD age of 42.9 ± 8.8  tion of traditional cigarette as verified by exhaled
  years Regular smokers (mean ± SD):  carbon monoxide
  34.9 ± 14.7 pack/years
Kralikova et al., (2013). Interview of people on the street   2012 respondents,  age 34 year mean,  About 20% of smokers who try e-cigs go on to
  17 cities across the Czech republic  become regular e-cig users. 
Pokhrel et al., (2013) . Cross sectional survey of Hawaiin i 
 slanders recruited from 2010 to 2012  1567 repondents divided in two  Smokers who tried E-cigs is more confident to quit 
  groups .ever e-cig users(n = 202)  smoking .
  mean age 42 ± 1 years , never e-cig  
  users (n = 1365), mean age 46 ± 0.4  
  years  
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rette failed to induce changes in hemodynamic parameters that usually 
associated with traditional smoking (Czogala et al., 2012).
The study by Goniewicz et al., (2013) after switching from tobacco 
to electronic cigarettes nicotine exposure were unchanged while expo-
sure to selected toxicants was substantially reduced Goniewicz et al., 
2013).
Flouris et al.,( 2013) carried out study on 15 cigarette smokers and 
15 never smokers who used the same brand of E-cigarette. The study 
reported that, acute smoking, but not acute vaping induced increased in 
white blood cell lymphocyte which reflects sign of inflammation and 
significant decrease in forced expiratory volume in one second (FEV1) 
whereas vaping lacking these effects.
Farsalinos and Romagna (2013) mention in a case report that, smok-
ing cessation and use of e-cigarette reversed the symptoms of chronic 
idiopathic neutrophilia in a 28 year old male patient.
A study on 18 heavy smokers with mild to moderate asthma symp-
toms using a regular dose of inhaled corticoids and long acting beta ago-
nists gone through pulmonary function tests before and after 6 and 12 
months of E-cig use. Smokers with asthma who switched to E-cigs, 
found no adverse effects, rather e-cigs users shown significant improve-
ment in FEV1. Further author stated that out of 18 smokers 10 quit 
smoking completely and reaming 8 become dual users, decreased their 
consumption of cigarettes from average of 22.4 at baseline to 3.9 day 
after 12months (polosa R et al., 2014).
A recent study compared the acute effects of smoking and E-cigs on 
myocardial function on 36 healthy smokers and 40 vapers respectively. 
The study stated that, e-cigs has no immediate effect on myocardial 
function as compare to smoking, which causes delay in myocardial 
relaxation. But further author suggested that, to conclude firmly for long 
term beneficial effects, intense study should be performed on smoker's 
health (Farsalinos et al., 2014).
In comparison with above analysis, the below studies shown unde-
sirable impact of e-cigarette and vaping on health. 
Bahl et al., (2012) mention mixed response of e-cigarette on Human 
embryonic stem cells and pulmonary fibroblasts carried out on In vitro 
cultures. The study shown that, nicotine in e-cigarette refill fluid had no 
cytotoxic effect on the Human embryonic stem cells where as the num-
ber and concentration of chemicals other than nicotine used to flavour 
e-cigarette refill fluids increased cytotoxity.
McCauly et al., (2012) mention in a case report that, stopping of 
e-cigarette use cleared the exogenous lipoid pneumonia in a 42 year old 
woman, but the case study does not publicized that patient is a current 
or ex-smoker (McCauly et al., 2012).
A case of atrial fibrillation in an elderly person after E-cig use has 
been reported. But report further explains, this could be the effect of 
nicotine on autonomic nervous system (Monroy. A.E et al., 2012).
A study done by Vardavas et al., (2012) on 10 healthy smokers to 
find out the effect of E-cigs on pulmonary functions shown, after acute 
ad libitum puffing from e-cig (Nobacco,11 mg/ml of nicotine) for five 
minutes, found no effect on spirometry but shown 18% dynamic airway 
resistance and 16% decreased expired nitric oxide. The limitation of this 
study is small sample size. Even though this study suggest that e-cigs 
constricts peripheral airways which could be particular concern to 
COPD, Asthma, emphysema and bronchitis people and some authors 
conclude this effect, is a sign of pulmonary inflammation (Schober et 
al., 2013).
A case report by thota, and latham, (2014) mention, electronic ciga-
rettes possibly associated with acute eosinophilic pneumonitis (AEP) in 
a previously healthy 20 year old active-duty sailor. The data suggested 
that, there could be a link between use of e-cig and AEP. But author fur-
ther stated that studies are needed to establish a correlation between 
these two (Thota, and Latham.,2014).
An outline of the studies involving safety of e-cig summarized in 
the Table 2
Studies on Chemical Analysis of E-Cigarette
The review on chemical analysis, address the safety of the e-cigs. It 
has been found that, nicotine content of the e-liquids in the cartridges 
from some brands, failed to claim labelled and actual nicotine content.
(Goniewicz et al., 2013;Cameron et al., 2014) and also many questions 
are raised for the contents of E-cigs, even though there is more compre-
hensive knowledge of the chemical constituents of e-cigarette than 
tobacco ones (Cahn and Siegel, 2010). 
Cigarette smoke from burn tobacco products contains thousands of 
compounds, many of which have been exposed to promote carcinogene-
sis such as trace elements (i.e., cadmium, arsenic, chromium, nickel and 
lead), the tobacco specific N-nitrosamines (TSNA), the polycyclic aro-
matic hydrocarbons (PAH), and volatile organic compounds (VOCs)
(Rodgman and Perfetti.2009; Talhout R et al., 2011). 
As mention above the main basic ingredients of E-cigs liquids are 
propylene glycol and glycerine. Propylene glycol is considered?general-
ly recognized as sa fe (GRAS) by the U.S . Food and Drug 
Administration (USFDA). But the literature survey revealed that it can 
cause eye and respiratory irritation, long and repetitive inhalation may 
affect central nervous system(MDSS,Sciencelab.com).when propylene 
glycol heated or vaporised can form propylene oxide and as per interna-
tional agency for research on cancer it is a class 2B carcinogen (laino et 
al.,2012).whereas glycerol on heating may forms acrolien, which can 
causes upper respiratory tract irritation(US EPA).some physical injuries 
and illness also reported by e-cig use, due to explosions and fires (Chen 
IL, 2012; CBS News 16,2012).
Apart from above debated questions, the below studies also reported 
toxicants and impurities found in E-cigs liquids, cartridges and mists. 
The study done by FDA found, some small amounts of diethylene 
glycol (DEG) approximately 1% and, tobacco specific nitrosamines 
(TSNAs). DEG is known carcinogen and ingredient use as anti-freeze, 
detected in one out if 18 cartridges analysed by FDA. The cause of the 
DEG contamination is not apparent but could reveal the use of 
non-pharmaceutical grade propylene glycol (Laugesen M., 2008).
The study done by Westenberger BJ (2009), FDA division of phar-
maceutical analysis department and Cobb NK and Abrams DB (2011) 
revealed that, the ingredients chiefly found in e-cigarette are Nicotine, 
propylene glycol, glycerine and tobacco flavouring agents. The study 
further mention that, propylene glycol, a FDA approved solvent for 
foods and vehicle for some injections as the major constituent found in 
e-cig fluids, make up about 90% of the solution (Westenberger 
BJ.,2009).
In another study held by Laugesen M (2008) approved by Health 
New Zealand ltd (HNZ) found levels of arsenic, cadmium, chromium, 
nickel and lead to be undetectable in e-cig cartridge liquid along with 
trace amount of TSNAs .
Cahn and seigel (2010) determine the levels of TSNAs in various 
cigarettes and nicotinic delivery products including e-cig .The study 
shown that, TSNAs in e-cigs were very low compare to various ciga-
rettes brands but slight high against Nicorette gum and Nicoderm CQ 
patch. (Table 4) 
A few other studies also inveterate some low levels of TSNAS, 
undetectable levels of particulate matter, trace elements, VOCs, and 
PAHs in cartridges and refill solution of e-cigarettes (McAuley et al., 
2012; Goniewicz ML et al., 2013; Schripp T et al., 2013; Kim HJ and 
Shin HS.2013; Pellegrino et al., 2012).
FDA issued warning to several e-cigs companies for selling e-car-
tridges and refill solutions containing active pharmaceutical substances 
(Woodcock J, 2013). Analysis of some e-cigarettes cartridges and solu-
tions revealed the presence of some active pharmaceutical ingredients 
such as rimonabant (Zimulti) and aminotadalafil, although the amount 
of these substances that is able to transfer from liquid to vapour phase is 
low (Hadwiger ME et al., 2010; Moorea TW et al., 2011).
Farsalinos et al., (2014). Worldwide Internet survey  over  19414  Participants were age > 18.  E-cigs effective in highly-dependent smokers and
  respondents divided into two groups , used as long-term substitutes for smoking. The 
  current and former smokers study also reported 57.9% participants reported at 
   least one symptoms and the most common side 
   effect were dry mouth and sore throat (38.9%).
Brown J et al., 2014 A Large cross sectional  5863 smokers observed for quit  Smokers who more likely to report for abstinent are 
  smoking in three groups E-cig,  E-cig users compare to NRT and going cold turkey.
  NRTand cold turkey without any 
  professional support 
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The analysis done by (Cheah et al., 2012; Cameron et al., 2013) on 
various brands of e-cigs cartridges and solution to determine the nico-
tine and its impurities reported that, Variable nicotine content in car-
tridges of same brands, inconsistency with product labelling and mis-
leading information on labels raised e-cig safety (Cheah et al., 2012; 
Cameron et al., 2013).
Similar to above study, another investigation done by Kim and shin 
(2013), reported related results. The analysis done on 105 refill fluids 
from 11 companies in Korea, founds a three order amount variation in 
TSNA concentrations, ranging from 330-8600 mcg/ml.
In contrast to above study, the analysis done by Etter et al., (2013) 
on numerous brands of e-cig refill solutions, revealed nicotine content 
to be precise and reliable to what was printed on the label (Etter et al., 
2013).
The chemical analysis done by Goniewicz et al., (2014), to deter-
mined toxic and carcinogenic compounds on twelve brands of E-cigs 
aerosols, tobacco cigarette and nicotine inhaler revealed that, the levels 
of toxicants in the e-cigs aerosol were 1 to 2 orders of lower magnitude 
than tobacco cigarette but higher than nicotine inhaler .(Table 5)
The studies involving chemical analysis of e-cigs summarized in the 
Table 3.
DISCUSSION
Electronic cigarettes use or vaping gaining attractiveness world-
wide. Their usage is greatly debatable as scientific outlook. Despite 
rapid market penetration of e-cigs still many question are unclear about 
their safety, efficacy for harm reduction and total impact on public 
health. Now e-cig becomes a global debate, with authorities wanting to 
ban it or legalize it. Given the debated nature to e-cigs, the medical 
Table 2. summary of studies described safety of Electronic cigarettes.
Authors E-cig Parameters tested Study Design Key findings
 brands
Eissenberg Njoy Plasma nicotine and heart rate  16 smokers, naïve to e-cigarettes  Smoking, but not vaping, raised   
(2010). Crown Seven measured before and after 10  were cycled through the four  plasma nicotine  and heart  rate.
  puffs of each device on four  different groups 
  different groups. .
Vansickel et al., 2010) Njoy Plasma nicotine ,carbon 16 smokers, naïve to e-cigarettes  Nicotine, expired carbon monoxide
 Crown Seven monoxide and heart rate  were cycled through the four  nd heart rate all raised after smoking,
  taken before and after 10  different groups. a but not vaping
  puffs on different groups    
Etter and Bullen., (2011). Own brand e-cig Salivary cotinine and heart  E-cig users vaped ad libitum but  Vaping and smoking induced similar 
  rate  abstained from cigarette and NRT  increased in salivary cotinine and heart 
   for 48 hrs. rate.
Czogala et al., (2012). Not mention  Systolic pressure Hemodynamic parameters are Vaping e-cigarettes fail to induce the 
  Diastolic pressure measured in smokers after  typical hemodynamic parameters 
  Pulse, Heart rate smoking cigarette or vaping  linked with traditional smoking.
Vansickel et al. ,(2012). Vapour Plasma nicotine concentration, Twenty smokers ,not currently  e-cig substantially deliver nicotine, 
 King heart  rate, urge to smoke  using e-cig were cycled through  increase  heart rate, reduced 
  cigarette, and nicotine   four experimental sessions withdrawal symptoms and urge to 
  withdrawal symptoms tested   smoke
  in four smokers
Dawkins and corcoron., (2013) First generation  Plasma nicotine Tobacco  14 E-cig users abstinent from  Vaping helped in reducing tobacco 
 e-cig (18 mg/ml withdrawal symptoms Urge to  smoking and vaping for 12 hr  related withdrawal symptoms and urge 
  smoke before test period. to smoke.
Farsalinos and Romagana.,(2013). Case report A 28 year old male with   Smoking abstinence and use of e-cig
  chronic idiopathic   reversed symptoms of chronic
  neutrophilia   idiopathic neutrophilia.
Flouris et al.,(2013). Giant,Nobacco Repeated measures controlled 30 smokers gone through a e-cig use induced smaller changes in
 GP Greece study control session, active smoking  pulmonary function but similar
 (11mg/ml)   and active vaping session nicotinergic impact compared to 
    smoking
Vansickel and Eissenberg.,(2013). Own brand Plasma nicotine  Blood samples were collected at Vaping and smoking induced similar 
  Heart rate baseline and after I hr ad libitum  increased in plasma nicotine and heart  
    rate
Thota and latham (2014).  Case report Acute  eosinophilic  E-cig possibly associated with  The data suggested that, there could be
  pneumonitis(AEP). eosinophilic pneumonitis in a  link between use of e-cig and AEP. 
   previously healthy active-duty  Further studies are needed to establish
   sailor. a correlation.
Monroy. A.E et al., 2012). Case report  Atrial fibrillation  Elderly person  E-cig reported to induced atrial  
    fibrillation.
Farsalinos et al., (2014). eGO-T battery  36 healthy smokers average Ecocardiographic examination E-cigs does not show any immediate
 (nobacco ,Athens , age 36 ± 5, 40 E-cig users and myocardial performance index effect on myocardial function whereas
 greece average age 35 ± 5 before and after use of tobacco cig tobacco cig causes delay in myocardial
   and E-cigs  relaxation. 
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community are in quandary to advice this as a smoking cessation aid to 
their patients. Most of the studies reported mix response regarding e-cig 
effectiveness and safety. Maximum of the studies done on internet, that 
is consumer based surveys regarding personal view on vaping, some 
observational studies (Caponnetto, Polosa, Russo, Leotta, & Campagna, 
2011; Farsalinos & Romagna, 2013; Schneiderhan, 2012) , few random-
ized trials (Bullen et al., 2013; Caponnetto, Campagna, et al., 2013) 
,one large scale cross sectional study (Brown et al.,2014) Suggest that 
e-cigs help smokers quit or reduce smoking. Outside these clinical stud-
ies, few longitudinal studies of vapers have been published (Adkison et 
al., 2013; Vickerman, Carpenter, Altman, Nash, & Zbikowski, 2013) 
and it is still unclear how the behaviour of vapers evolves over time.
The evaluation from above limited studies on inadequate partici-
pants with short time periods from some countries on electronic ciga-
rettes without sufficient data worldwide about its safety, effectiveness 
and health impact cannot accomplish e-cigarettes is harmless in com-
plete terms. In order to conclude firmly, still more research is needed 
globally in different population to look at its long-term safety and effec-
tiveness particularly on cardiovascular diseases and on smoker's health 
from different parts of the world. Our literature survey shown USA, 
Table 3. Summary involved Studies of Chemical Analysis of Electronic Cigarettes.
Authors E-cig Substance Analysis  Key findings
 brands tested   
Laugesen  Ruyan TSNA, MAO-A and B LC-MS, Flourometric assay TSNAs found but much lower than tobacco cigarette not 
(2008).  inhibitors, PAH, Heavy  GS-MS, ICP-MS, CO analyser carcinogenic level, PAH, heavy metals undetectable.
  metals, CO  Exhaled eCO does not increase after e-cigarette use.
Westenberger  Njoy, Smoking  TSNA, DEG, Tobacco  LC-MS, GC-MS, GC-MS TSNA,DEG present, Tobacco specific impurities present
(2009). FDA  every Where specific impurities  Measured Nicotine in several e-cig solutions is irregular to be in safe.
Study. 
Hadwiger et al., Not mention  Amino Tadalafil  HPLC-DAD-MMI-MS Amino tadalafil and Rimonabant present
(2010),  Rimonabant   Presence of nicotine in products labelled as containing no nicotine
FDA Study    
Trehy et al.,  Njoy, Smoking  Nicotine related  HPLC-DAD Nicotine related impurities present.
(2011). every Where impurities  
FDA Study  CIXI, Jhonson    
 creek   
Cheah et al., 20 different  Nicotine contents in GC-MS and  Visual inspection   Variable nicotine content in cartridges of same brands, inconsistency
(2012) brands of e-cigs cartridges and e-cig  of produc with product labelling and misleading information on labels raised
  quality.  e-cig safety.
Goniewicz et al., eleven Carbonyls, VOC HPLC-DAD,GC-MS, TSNA,VOC, and carbonyl compounds were found to be 9 to 450 
(2012). polish brands  TSNA, Heavy metals. UPLC-MS, ICP-MS times lower in e-cigs mist compare to conventional cigarette smoke.
 and one English 
 brands  
McAuley et al., Not mention  TSNA, PAH, DEG, GC/MS,GC/MS,GC/MS, TSNA, PAH, diethylene glycol, VOC, and carbonyls in e-cigarette 
(2012).  VOC Carbonyls HS-GC/MS HPLC-UV mist were all negligible compared to cigarette smoke.
Pellegrino et al.,  Italian  brands  Particulate matter Particle counter and smoking  Particulate matter found in E1cig mist but lesser than cigarette smoke.
(2012). of e-cigarettes   Machine 
Schripp et al .,  Three  VOC, Particulate  GC-MS, Particle counter and  VOC in e-cig cartridges, solution and mist but lower than tobacco  
(2012). unidentified  Matter smoking machine. cigarette, PM is low in e-cig mist compared to cigarette smoke.
 brands   
Cameron et al., Vapour liquid Nicotine content in LC-MS Nicotine levels in e-cig solutions were too irregular to be reflected
(2013).  Smart smoke,  solutions and   unsafe.
 BE112 No  cartridges  
 brand liquid      
Kim and Shin 105 liquids TSNA LC-MS TSNA are present at low levels in e-cigarette replacement fluids
(2013).  brands from 11    
 korean e-cig    
 companies   
Etter et al.,  10 brands of  Nicotine contents, GC and LC Measured Nicotine content in refill liquids are similar as indicated on
(2013). refill liquids  nicotine degradation   the label. Impurities found but below dangerous level.
  and  its impurities   
Williams et al.,  Not mention  Heavy metals ICP-MS, Particle counter and  Heavy metals and silicate particles found in e-cig mist
(2013).   Silicate particles  smoking machine, light and 
   electron microscope, 
   cytotoxity testing, x-ray, 
   Microanalysis.  
Abbreviations: TSNA= tobacco specific nitrosoamines;PM=particulate matter; LC-MS, = liquid chromatography-mass spectrometry; MAO-A  and
 B = monoamineoxidase A and B; PAH = polycyclic  aromatic hydrocarbons; GS-MS = gas chromatography - mass spectrometry; ICP-MS = inductively  coupled plasma  mass spectrome-
try; CO= carbon monoxide, VOC = volatile organic compounds; UPLC-MS = ultra-performance liquid chromatography-mass spectrometry; HPLC-DAD-MMI-MS =  high performance liq-
uid chromatography-diode array detector-multi-mode ionization-mass spectrometry.
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UK, Italy, Greece, new Zealand, Switzerland have higher E-cigs 
research output compare to other countries of the world, this indicate us 
there is necessity of E-cigs research globally including Malaysia to a 
make generalised statement about its safety and effectives. 
Although our literature survey from 2004 onwards but we found 
first article as per our objective topic in 2008. E-cigs research emerging 
more from 2009 to present date, indicating that research in progress. 
Despite its availability in most the countries except some countries they 
ban sale of electronic cigarettes with nicotine (Australia, Brazil, 
Canada, Mexico, Panama, Singapore and Switzerland) the data is lack-
ing country wise including Malaysia.
In our review literature survey many authors concluded that many 
questions about E-cigs use are unanswered, primarily effectiveness of 
this device as a smoking cessation aid, long term users and device safety 
and it use might promote nicotine addiction in non-smokers especially 
youth generation and has potentiality to renormalize smoking act. 
Presently very little research has been carried on human health in some 
nations. Existing available few studies largely conducted on healthy 
peoples with short time exposure revealed that, minor side effects like 
mouth irritation, dry cough, nausea, vomiting and with little or no 
effects on pulmonary and cardiovascular functions without any serious 
side effects and withdrawal symptoms have been reported with e-cig 
use. But lot of questions upraised about the safety of its basic contents 
like propylene glycol that cause respiratory irritation, bronchial con-
striction and about engineering of the device. The study conducted by 
FDA found TSNAs and DEG, PAH, VOC and some trace elements in 
lower quantities, detected in electronic cigarettes cartridges, solutions 
and mists, open lot of questions regarding its quality, regulations and 
health issues.
Our study is not without limitations, as per the topic and searching 
key words and narrative nature of this manuscript only original articles 
that reported mainly safety, effectiveness and chemical analysis of elec-
tronic cigarettes in above mention databases were included. Despite 
some articles cited with other topics or key words might be missed and 
might give some important information regarding safety and effective-
ness of E-cigs. Additionally articles published other than these data-
banks and published in other languages such as German and French 
were not selected, might give some important information regarding 
safety and effectiveness was missed. 
CONCLUSION
Due to limited studies with inadequate participants and short time 
exposure in some developed countries, e-cig cannot accomplish safe and 
effective. In order to conclude decisively, still more research is required 
globally in different population to look at its long-term safety and effec-
tiveness particularly on cardiovascular diseases and on smoker's health 
from different parts of the world including Malaysia. Hence, the current 
literature review does not warrant a conclusion that electronic cigarettes 
are safe and effective smoking aid in absolute terms. In view of this, it is 
important to investigate and establish the long term safety and effective-
ness of these devices in order to ensure that, the decisions of regulators, 
healthcare providers and consumers are based on science.
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